Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-01-11

Clinical Trial Update: Safety and Efficacy of Repeated Doses of PMI-150 (Intranasal Ketamine) in Acute Post-operative Pain Following Orthopedic Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of repeated doses of PMI-150, an intranasal ketamine, for acute postoperative pain after orthopedic surgery; st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PMI-150 (intranasal ketamine) (ketamine)

Snippet

Sponsor: Hospira, now a wholly owned subsidiary of Pfizer | Conditions: Pain, Postoperative | Phase 3 | Status: COMPLETED